36/72 PS Tower, Sukhumvit 21 Rd., Klongtoey-Nua
Wattana, Bangkok 10110
Thailand
Phone: (66) 2 664 4290-3
Fax: (66) 2 664 4289
E-Mail: jerry@theravitae.comThis e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Description:
TheraVitae offers the very latest in stem cell therapy to help patients who have been told that there is little the medical profession can do to help them. We are dedicated to developing new stem cell treatments to cure diseases once deemed incurable. At TheraVitae, our goal is make our stem cell therapies accessible and affordable to the millions of people suffering from diseases once seen as incurable.
A good quality of life is vital to all of us, and TheraVitae is committed to being a global leader in helping people change their lives for the better using their own stem cells to heal them. We offer hope to people who refuse to accept that they must live their remaining days condemned to being incapacitated and restricted in their activities and pleasures.
Our core values are to demonstrate excellence, compassion and integrity in all that we do. We are committed to the highest professional, ethical and moral standards to work with and for our patients and we will do our best to return them to health.
The patients’ and our own goals will be achieved by the development and use of stem cell therapies using autologous (the patient’s own) stem cells – stem cells that originate from the person to whom the cells in enriched form will be administered. TheraVitae patented process uses the patients own stem cells derived from a simple, painless blood donation. There is absolutely no danger of immunological incompatibility(graft vs. host disease) between donor and host because they are a perfect DNA match.
VesCell™ for Heart Disease
TheraVitae’s initial product- VesCell for Heart Disease is now being used to improve the quality of life of patients suffering from coronary heart disease, congestive heart failure and cardiomyopathy. Symptoms such as severe angina pectoris (chest pain) and shortness of breath are relieved.
VesCell™ for Peripheral Artery Disease (PAD)
VesCell for PAD is the latest adult stem cell therapy developed by TheraVitae. The patient’s own adult stem cells are injected into their lower legs under a local anesthesia. The adult stem cells have the ability to create new blood vessels. These new blood vessels increase the blood flow to the lower limbs.
Future Products
Starting with heart disease and then peripheral artery disease, TheraVitae has an unparalleled track record in developing adult stem cell therapies and bringing them to the market. TheraVitae’s researchers continue to work around the clock to ensure the best for our patients in the near future.
For additional information contact Jerry Steele, Outreach Director, Theravitae, Co., Ltd. +66(2)664-4290, jerry@theravitae.com
More Details : http://www.theravitae.com or http://www.vescell.com